DALLAS, November 19, 2014 /PRNewswire/ --
The report "Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), By Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), By Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018", published by MarketsandMarkets, analyzes and studies the major market drivers, threats, opportunities, and challenges for Synthetic Biology Market.
Browse 99 market data tables and 46 figures spread through 185 pages and in-depth TOC on "Synthetic Biology Market - Global Forecast to 2018"
Early buyers will receive 10% customization on this report.
This report studies the global Synthetic Biology Market for the forecast period of 2013 to 2018. This market is expected to reach $5,630.4 Million by 2018 from $1,923.1 Million in 2013, growing at a CAGR of 24% during the forecast period.
The global Synthetic Biology Market is segmented on the basis of tools, technologies, applications, and geographies.
On the basis of tools, the Synthetic Biology Market is categorized into Xeno-nucleic acids, chassis organisms, Oligonucleotide, enzymes, and cloning and assembly kits. The Oligonucleotide segment accounted for a major share of the synthetic biology market, by tool, in 2013.
On the basis of technologies, the Synthetic Biology Market is segmented into enabled and enabling technologies. Enabling technologies accounted for a major share of the Synthetic Biology Market in 2013. On the basis of applications, the Synthetic Biology Market is segmented into environmental, medical, and industrial applications. The medical applications segment accounted for a major share of the Synthetic Biology Market in 2013.
On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and Middle East and Africa. North America accounted for the largest share of the synthetic biology market, followed by Europe and Asia. However, the European market is expected to grow at the highest CAGR in the coming five years, and serves as a revenue pocket for the companies involved in the manufacturing of synthetic biology products.
Over the years, the demand for synthetic biology is likely to increase owing to the increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in the field of synthetic biology. However, ethical and social issues such as bio safety and bio security are major factors that are restricting the growth of this market. Furthermore, rising concerns over fuel consumption and increasing demand for protein therapeutics are likely to create opportunities for the synthetic biology market. However, standardization and integration of biological parts at system-level still remains a challenge for this market.
Some of the major players in the global Synthetic Biology Market include Amyris, Inc. (U.S.), DuPont (U.S.), GenScript USA, Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT) (U.S.), New England Biolabs, Inc. (NEB) (U.S.), Novozymes (Denmark), Royal DSM (Netherlands), Synthetic Genomics, Inc. (California), and Thermo Fisher Scientific, Inc. (U.S.).
Browse related reports
Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019
Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Email: [email protected]
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology